We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+48.16%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$28.7B
AUM Growth
+$9.02B
(+46%)
Cap. Flow
+$410M
Cap. Flow
% of AUM
1.43%
Top 10 Holdings %
Top 10 Hldgs %
40.88%
Holding
1,054
New
51
Increased
542
Reduced
395
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinox Gold
EQX
|
+$133M |
| 2 |
B
Barrick Mining
B
|
+$122M |
| 3 |
Franco-Nevada
FNV
|
+$94.4M |
| 4 |
Newmont
NEM
|
+$93.9M |
| 5 |
Boeing
BA
|
+$64.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UHT
Universal Health Realty Income Trust
UHT
|
+$103M |
| 2 |
Kinross Gold
KGC
|
+$89.9M |
| 3 |
Core Laboratories
CLB
|
+$82.3M |
| 4 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$71.6M |
| 5 |
Amazon
AMZN
|
+$65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 59.42% |
| 2 | Technology | 12.22% |
| 3 | Healthcare | 5.75% |
| 4 | Financials | 3.68% |
| 5 | Energy | 3.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MXIM
126
DELISTED
Maxim Integrated Products
MXIM
| $38.8M | 0.14% |
640,318
-38,538
| -6% | -$2.15M |
|
127
Bilibili
BILI
$7.99B
| $38.6M | 0.13% |
834,297
+614,241
| +279% | +$19.9M |
|
128
Kirby Corp
KEX
$7.01B
| $38.6M | 0.13% |
719,970
-700
| -0.1% | -$35.8K |
|
129
Electronic Arts
EA
$53B
| $38.5M | 0.13% |
291,740
+186,752
| +178% | +$22.1M |
|
130
Teradyne
TER
$57.6B
| $38M | 0.13% |
449,607
+32,903
| +8% | +$2.21M |
|
131
Marvell Technology
MRVL
$168B
| $37.5M | 0.13% |
1,070,506
-112,290
| -9% | -$3.29M |
|
132
Idexx Laboratories
IDXX
$44.1B
| $36.8M | 0.13% |
111,477
-17,548
| -14% | -$5.08M |
|
133
Vanguard S&P 500 ETF
VOO
$979B
| $36.2M | 0.13% |
127,658
-49,788
| -28% | -$13.4M |
|
|
PXD
134
DELISTED
Pioneer Natural Resource Co.
PXD
| $35.9M | 0.13% |
367,879
+76
| +0% | +$6.7K |
|
135
NetEase
NTES
$85.3B
| $35.5M | 0.12% |
413,820
+264,825
| +178% | +$19.9M |
|
136
New Oriental
EDU
$9.37B
| $35.5M | 0.12% |
272,690
+27,640
| +11% | +$3.37M |
|
137
IPG Photonics
IPGP
$3.61B
| $34.2M | 0.12% |
213,500
-1,726
| -0.8% | -$246K |
|
|
PE
138
DELISTED
PARSLEY ENERGY INC
PE
| $33.8M | 0.12% |
3,168,939
+1,653
| +0.1% | +$15.3K |
|
139
Johnson & Johnson
JNJ
$618B
| $33M | 0.12% |
234,925
+36,084
| +18% | +$5.26M |
|
140
Ares Capital
ARCC
$13.5B
| $32.4M | 0.11% |
2,244,019
-217,643
| -9% | -$2.94M |
|
141
Union Pacific
UNP
$174B
| $32M | 0.11% |
189,407
+327
| +0.2% | +$52.4K |
|
142
Take-Two Interactive
TTWO
$45.4B
| $30.9M | 0.11% |
221,607
+148,602
| +204% | +$19.4M |
|
143
Vertex Pharmaceuticals
VRTX
$121B
| $30.6M | 0.11% |
105,577
+30,833
| +41% | +$8.36M |
|
|
ZNGA
144
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $30.3M | 0.11% |
3,172,652
+1,873,495
| +144% | +$15.4M |
|
145
Diamondback Energy
FANG
$57.1B
| $29.5M | 0.1% |
706,062
-3,563
| -0.5% | -$145K |
|
146
Annaly Capital Management
NLY
$17.1B
| $29.2M | 0.1% |
1,114,129
+382,900
| +52% | +$9.46M |
|
147
Qorvo
QRVO
$7.99B
| $28.9M | 0.1% |
261,533
-4,938
| -2% | -$489K |
|
148
Illumina
ILMN
$31B
| $28.1M | 0.1% |
77,993
+5,968
| +8% | +$1.92M |
|
149
Regeneron Pharmaceuticals
REGN
$78.5B
| $28M | 0.1% |
44,877
+7,489
| +20% | +$4.25M |
|
150
Visa
V
$684B
| $27.9M | 0.1% |
144,594
+24,340
| +20% | +$4.45M |
|
Similar funds
VanEck Associates's Q2 2020 Portfolio in Review
As of Q2 2020, VanEck Associates held 1,054 positions worth $28.7B, up 46% from $19.7B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
VanEck Associates's Q2 2020 filing shows 51 new, 542 increased, 395 reduced and 49 closed positions. Its largest new stake was DRDGold: 4,905,868 shares worth $77.5M. The largest sale was Universal Health Realty Income Trust, an estimated $103M.
By sector, the portfolio is most concentrated in Materials at 59% of assets, up from 55% a quarter earlier, followed by Technology and Healthcare.
- VanEck Associates's largest Q2 2020 buy was DRDGold: 4,905,868 shares worth $77.5M.
- VanEck Associates added most to Equinox Gold in Q2 2020, an estimated $133M increase.
- VanEck Associates's biggest Q2 2020 reduction was Universal Health Realty Income Trust, cutting an estimated $103M.
- VanEck Associates fully exited Raytheon Company in Q2 2020, selling an estimated $32.3M.
- VanEck Associates's ten largest holdings make up 41% of its $28.7B portfolio in Q2 2020.
- VanEck Associates opened 51 new positions and closed 49 in Q2 2020.
- VanEck Associates's portfolio value rose 46% quarter-over-quarter to $28.7B.
Based on VanEck Associates's 13F filing for Q2 2020, filed 10 Aug 2020.